Results 51 to 60 of about 278,227 (245)
Nonsurgical treatment for upper eyelid retraction in patients with inactive Graves’ orbitopathy
Purpose To evaluate the effectiveness of incobotulinumtoxinA (Xeomin^®) in treating upper eyelid retraction in patients with Graves orbitopathy (GO) initially scheduled for surgery via two different application sites.
Sandra Vokurka Topljak +5 more
semanticscholar +1 more source
Objective Graves’ disease (GD) is the main cause of hyperthyroidism among adults. It is an autoimmune condition classically marked by the Merserburg Triad (goiter, thyrotoxicosis, and orbitopathy), but the change in presentation of GD over time has ...
Wanesa Pinto +4 more
doaj +1 more source
Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial):Study protocol for a randomized controlled trial [PDF]
BACKGROUND: Graves’ hyperthyroidism is an autoimmune disease causing hyperfunction of the thyroid gland. The concentration of selenium is high in the thyroid gland and two important groups of enzymes within the thyroid are selenoproteins, that is, they ...
Bach-Mortensen, Pernille +16 more
core +1 more source
High IgG4 serum concentration is associated with active Graves orbitopathy
Background The aim of the study was to evaluate the differences in clinical profile, laboratory parameters, and ophthalmological signs, and symptoms between patients with high IgG4 Graves orbitopathy and patients with normal IgG4 Graves orbitopathy ...
Michał Olejarz +7 more
semanticscholar +1 more source
Strabismus surgery in topical anaesthesia with intraoperative suture adjustment in Graves' orbitopathy. [PDF]
Abstract Purpose To report the results of strabismus surgery in a series of patients with Graves' orbitopathy (GO), using topical anaesthesia with intraoperative suture adjustment. Methods All first‐time strabismus surgeries in patients with GO in our department during the years 2014–2021 (n = 45) were assessed retrospectively.
Haugen OH +3 more
europepmc +2 more sources
The most frequent extrathyroidal Graves’ disease manifestation is Graves’ orbitopathy (GO). The treatment of GO is determined by its severity and activity.
Anna Ochmann +3 more
semanticscholar +1 more source
Teprotumumab for Thyroid-Associated Ophthalmopathy [PDF]
BACKGROUND: Thyroid-associated ophthalmopathy, a condition commonly associated with Graves’ disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns ...
Antonelli, A +18 more
core +1 more source
Associations between Lipid Profiles and Graves’ Orbitopathy can Be HLA-Dependent
The risk of Graves’ orbitopathy (GO) is related to the human leukocyte antigen (HLA) profile and was demonstrated to be increased in patients with elevated total cholesterol (TC) and/or low-density lipoprotein (LDL) cholesterol.
M. Stasiak +4 more
semanticscholar +1 more source
Background When quantitative magnetic resonance imaging (MRI) is used to assess the activity of Graves’ orbitopathy (GO), the examination is generally focused on a specific orbital tissue, especially the extraocular muscles (EOMs).
Jingyi Cheng +11 more
semanticscholar +1 more source
Isolated primary amyloidosis of the inferior rectus muscle mimicking Graves’ orbitopathy
The diagnosis of Graves’ orbitopathy is usually straightforward. However, orbital diseases that mimick some clinical signs of Graves’ orbitopathy may cause diagnostic confusion, particularly when associated to some form of thyroid dysfunction.
Mário Luiz Ribeiro Monteiro +2 more
doaj +1 more source

